The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.


Updates from The Motley Fool

Latest updates on Sangamo Biosciences from Fool.com.


Stock Performance

SGMO vs. S&P 500 | 2 Year Performance
View Interactive SGMO Charts
Sponsored by

Key Data Points

Primary metrics and data points about Sangamo Biosciences.
Current Price: $4.29
Prev Close: $4.34
Open: $4.31
Bid: $4.22
Ask: $4.32
Day's Range: $4.19 - $4.44
52wk Range: $4.08 - $9.91
Volume: 851,300
Avg Vol 979,883
Market Cap: $300.50M
P/E (ttm): -4.62
EPS (ttm): -$0.94
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Sangamo Biosciences.
CAPS Rating 4 out of 5
 
268 Outperform
16 Underperform
CAPS All Stars
 
53 Outperform
5 Underperform

How do you think Sangamo Biosciences will perform against the market?



You pick for Sangamo Biosciences is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Sandy Macrae, M.B., Ch.B., Ph.D., CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Sangamo Biosciences.

The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers